Aurora Spine Corporation
Other OTCTotal Valuation
Aurora Spine Corporation carries a market capitalization of 10.39M, placing it among publicly traded companies globally. Its enterprise value stands at 16.79M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.39M |
| Enterprise Value | 16.79M |
Share Statistics
Aurora Spine Corporation currently has 78.09M shares outstanding.
| Shares Outstanding | 78.09M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.80, and the price-to-book ratio stands at 4.84.
| PE Ratio | N/A |
| PS Ratio | 0.80 |
| PB Ratio | 4.84 |
| P/TBV Ratio | 6.08 |
| P/FCF Ratio | 11.99 |
| P/OCF Ratio | 20.22 |
Enterprise Valuation
On an enterprise value basis, Aurora Spine Corporation trades at an EV/EBITDA multiple of 110.73 and an EV/FCF ratio of 12.71.
| EV / Sales | 0.96 |
| EV / EBITDA | 110.73 |
| EV / EBIT | N/A |
| EV / FCF | 12.71 |
Financial Position
Aurora Spine Corporation maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 123.31, indicating elevated leverage, while an interest coverage ratio of 0.98 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.25 |
| Quick Ratio | 1.02 |
| Debt / Equity | 123.31 |
| Debt / EBITDA | 22.98 |
| Interest Coverage | 0.98 |
Financial Efficiency
| Return on Equity (ROE) | -36.03 |
| Return on Assets (ROA) | -11.91 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.88 |
Stock Price Statistics
Aurora Spine Corporation's stock has declined approximately -24.68591% over the past 52 weeks. The 50-day moving average sits at 0.15, while the 200-day moving average is 0.18.
| Beta (5Y) | N/A |
| 52-Week Price Change | -24.68591% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.18 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Aurora Spine Corporation generated 17.55M in revenue and converted that into -1.22M in net income, yielding earnings per share of -0.02. EBITDA reached 151,607.00, while operating income came in at -891,694.00.
| Revenue | 17.55M |
| Gross Profit | 10.81M |
| Operating Income | -891,694.00 |
| Pretax Income | -1.22M |
| Net Income | -1.22M |
| EBITDA | 151,607.00 |
| EBIT | -891,694.00 |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
Aurora Spine Corporation holds 362,634.00 in cash and equivalents against 3.48M in total debt, resulting in a net debt position of 2.55M. Total book value stands at 2.83M, with working capital of 3.67M providing operational flexibility.
| Cash & Cash Equivalents | 362,634.00 |
| Total Debt | 3.48M |
| Net Debt | 2.55M |
| Equity (Book Value) | 2.83M |
| Book Value Per Share | 0.04 |
| Working Capital | 3.67M |
Cash Flow
Aurora Spine Corporation produced 691,257.00 in operating cash flow over the past twelve months. After subtracting -474,177.00 in capital expenditures, free cash flow totaled 217,080.00 - equivalent to 0.00 per share.
| Operating Cash Flow | 691,257.00 |
| Capital Expenditures | -474,177.00 |
| Free Cash Flow | 217,080.00 |
| FCF Per Share | 0.00 |
Margins
Aurora Spine Corporation operates with a gross margin of 61.61, reflecting its pricing power and cost economics. The operating margin of -5.08 and net profit margin of -6.95 provide insight into operational efficiency.
| Gross Margin | 61.61 |
| Operating Margin | -5.08 |
| Pretax Margin | -6.95 |
| Profit Margin | -6.95 |
| EBITDA Margin | 0.86 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 2.75 |
| FCF Yield | 8.34 |
Scores
Aurora Spine Corporation posts an Altman Z-Score of -1.17, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.17 |